Annual Drug Patent Expirations for SKYLA
Skyla is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
This drug has sixty-nine patent family members in twenty-eight countries.
The generic ingredient in SKYLA is levonorgestrel. One supplier is listed for this compound. Additional details are available on the levonorgestrel profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
